Dr Silvia Marsoni, Director of clinical research at The Institute for Cancer Research in Candiolo, talks to ecancer about primary and secondary resistance in colorectal cancer at the European Forum on Oncology in Berlin, May 2012.

Dr Marsoni’s project aims to understand how patients respond to EGF therapy and why the majority do not respond to treatment. In order to take this back to the lab, mouse models are used to mimic the immune system of the patient. The data can then be used, again, in the clinic to improve and treatment.